Evaluation of some biomarkers (phosphorus, Parathyroid hormone, Calcium, vitamin D) in patient's serum with chronic kidney disease (CKD)

Ola A.  Naser; Shatha Q . Al-Temimi; Hanaa S.  Kadhum; Mahdi M.  Thuwaini; Nabaa G.  Nasser; Tabarek N.  Abd; Nada N.  Hassan

doi:10.36371/port.2024.special.34

Authors

Ola A. Naser Department of Pathological Analysis, College of Science, Basrah University; Iraq.
Shatha Q . Al-Temimi Department of Medical Laboratories, College of Health and Medical Techniques, Basrah University; Iraq.
Hanaa S. Kadhum Department of Pathological Analysis, College of Science, Basrah University; Iraq.
Mahdi M. Thuwaini Department of Medical Laboratories, College of Health and Medical Techniques, Basrah University; Iraq.
Nabaa G. Nasser Department of Pathological Analysis, College of Science, Basrah University; Iraq.
Tabarek N. Abd Department of Pathological Analysis, College of Science, Basrah University; Iraq.
Nada N. Hassan Department of Pathological Analysis, College of Science, Basrah University; Iraq.

Abstract References Downloads Cite Statistics Share Information

Background chronic kidney disease (CKD) can be defined as abnormalities either in kidney structure or function by decreasing glomerular filtration rate (GFR) of less than 60 mL/min/1.73 m² for at least 3 months. it is considered to be a major medical problem, especially in developing countries and emerging economies. The study aims to measure biochemical markers (calcium, phosphorus, vitamin D, and PTH) in patients with CKD and healthy control, also finding out the effect of CKD on formation active form of vitamin D. Methods: This study includes (90) individuals (60) patients (30 males and 30 females) and (30) healthy control. The criteria of inclusion were: patients previously diagnosed with chronic kidney disease, In the study population age ranged between ( 30-70) years old for both groups who visited Al-Basra General Hospital in the province of Basra (The National Hemodialysis Project, artificial kidney Center) through period from November 2022 to February 2023.VIDAS was used to measure parathyroid hormone and vitamin D, while COBAS C111 was used to measure serum phosphorus and calcium levels, for both patients and healthy control groups. The results of the current study have shown that there was a high significant increase (P < 0.001) in the levels following biomarkers in CKD patients: PTH and phosphorus, the results also showed that a significant decrease was recorded in levels following biomarkers in CKD patients: serum calcium and vitamin D. There was also a positive relationship between the levels of calcium in patients with CKD and vitamin D while it was recorded that there was a negative relationship between the level of vitamin D with phosphorus and parathyroid hormone levels. In conclusion, the results of the current study have shown that there was a highly significant increase in PTH and phosphorus and a significant decrease in levels of serum calcium and vitamin D.

Keywords:

CKD, Biomarkers, phosphorus, Parathyroid hormone, Calcium, vitamin D

[1] Stevens P.E., Levin A. (2013) Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline. Ann. Intern. Med. 158:825–830. doi: 10.7326/0003-4819-158-11-201306040-00007.

[2] Luyckx V. A., Tonelli M. & Stanifer J. W. (2016) Causes of Death of Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study . 390:1151-210.

[3] Hill NR, Fatoba ST, Oke JL. et al. (2016)Global proof of chronic kidney disease- A systematic review and meta-analysis. PLoS One 11: e0158765.

[4] Zhang Q.L., Rothenbacher D. (2017). Prevalence of chronic kidney disease in population-based studies: Systematic review. BMC Public Health. 8:117. doi: 10.1186/1471-2458-8-117.

[5] Wilson P.D. (2004). Polycystic kidney disease. N. Engl. J. Med. ;350:151–164. doi: 10.1056/NEJMra022161.

[6] Glassock R. J., Warnock D. G. & Delanaye P. (2017). The global burden of chronic kidney disease: estimates, variability and pitfalls. Nature reviews. Nephrology. 13(2): 104–114 Cardiovascular

[7] Yang C.-W., Harris D.C.H., Luyckx V.A., Nangaku M., Hou F.F., Garcia G.G., Abu-Aisha H., Niang A., Sola L., Bunnag S., et al. (2020)Global case studies for chronic kidney disease/end-stage kidney disease care. Kidney Int. Suppl. ;10:e24–e48. doi: 10.1016/j.kisu.2019.11.010.

[8] Milovanova L., Y. Milovanov and A. Plotnikova (2009) , Phosphorus and Calcium Metabolism Disorders Associated with Chronic Kidney Disease Stage III-IV (Systematic Review and Meta-Analysis)

[9] Ritter C, Armbrecht H, Slatopolsky E, Brown A.( 2006) 25-Hydroxyvitamin D3 suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int.;70:654- 9. doi: 10.1038/sj.ki.5000394

[10] FERNANDO Liano, JuLio PASCUAL, and THE MADRID. (1996). Epidemiology of acute renal failure: A prospective, multicenter, community-based stud

[11] Girish N Nadkarni 1, Jaime Uribarri. (2013). Phosphorus and the kidney: What is known and what is needed. Review, Adv Nutr. 2014 Jan 1;5(1):98-103. doi 10.3945/an.113.004655

[12] Krishnasamy Narayanasamy, Rajendran Karthick, and A. Koodal Raj. (2018). Hypovitaminosis D Is Associated with Dysregulation of Calcium-parathyroid Hormone-vitamin D Axis in Patients with Chronic Liver Diseases. J Clin Transl Hepatol. 2019 Mar 28; 7(1): 15–20.

PDF

Naser, O. A. ., Al-Temimi, S. Q. ., Kadhum, H. S. ., Thuwaini, M. M. ., Nasser, N. G. ., Abd, T. N. ., & Hassan, N. N. . (2024). Evaluation of some biomarkers (phosphorus, Parathyroid hormone, Calcium, vitamin D) in patient’s serum with chronic kidney disease (CKD). Journal Port Science Research, 7(issue), 421–425. https://doi.org/10.36371/port.2024.special.34